Skip to main content
BioSenic SA logo

BioSenic SA — Investor Relations & Filings

Ticker · BIOS ISIN · BE0974280126 LEI · 549300HFIIMTOP1DFR76 BR Professional, scientific and technical activities
Open in API
Filings indexed 968 across all filing types
Latest filing 2023-09-01 Declaration of Voting R…
Country BE Belgium
Listing BR BIOS

About BioSenic SA

http://www.biosenic.com/

BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.

Recent filings

Filing Released Lang Actions
BIOS_PR_2023-septembre_Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE" (Press Release – Regulated Information) and is dated 01/09/2023. The core content details an update on the total number of voting rights and shares following the issuance of new shares due to convertible bond conversion. This type of mandatory disclosure regarding changes in the total number of shares and voting rights (the denominator for certain calculations) is a specific type of regulatory announcement. While it relates to capital structure changes (CAP) or major shareholding notifications (MRQ), the primary function here is the mandatory disclosure of the total share count as required by Belgian law (Article 15). Since it is a formal, periodic regulatory update concerning share capital structure changes, it fits best under the general category of regulatory filings or specific capital structure updates. Given the focus on the total number of shares and voting rights, it strongly aligns with announcements related to share capital changes or mandatory regulatory disclosures. The closest specific fit among the options that covers mandatory updates on share structure is 'Share Issue/Capital Change' (SHA) or the general 'Regulatory Filings' (RNS). Because the document is a formal press release announcing a change in the total number of shares and voting rights, which is a direct consequence of a capital event (conversion of convertible bonds), SHA is a strong candidate. However, since it is a formal regulatory disclosure of the denominator, and not just the issuance itself, RNS (Regulatory Filings) is often used for these mandatory, periodic updates that don't fit perfectly elsewhere, or SHA if the focus is purely on the resulting share count. Given the explicit mention of the change in 'Nombre total d'actions assorties de droits de vote' (Total number of shares with voting rights), SHA is highly relevant. I will classify it as SHA as it directly reports the outcome of a capital structure event (conversion). If SHA were not available, RNS would be the fallback. The document is a full announcement, not just a notice of publication (RPA).
2023-09-01 French
BIOS_PR_2023 08 25_Patent SEAL_ATO-Cu_EN_Final.pdf
Investor Presentation Classification · 95% confidence The document is explicitly titled 'PRESS RELEASE – INSIDE INFORMATION' and announces a specific corporate event: the issuance of a Chinese patent protecting the company's core technology (ATO platform). It details the patent number, scope, and strategic implications for clinical development. This type of announcement, focusing on intellectual property protection and strategic updates, is typically classified as a general corporate announcement or regulatory filing, but given the specific focus on IP and the format (Press Release), it aligns best with a general regulatory announcement or a specific update that doesn't fit the other categories. Since it is a formal announcement of a significant corporate event (patent grant) released to the public, and it is not a full financial report (10-K, IR), earnings release (ER), or a management discussion (MDA), the most appropriate general category for significant, non-financial, non-meeting related corporate news that must be disclosed is 'Regulatory Filings' (RNS), which serves as a broad category for official announcements not covered elsewhere. It is not a proxy statement (PSI), director dealing (DIRS), or capital change (CAP). The document length is substantial (10,892 chars), so it is not a Report Publication Announcement (RPA) which typically just announces the availability of another document.
2023-08-24 English
BIOS_PR_2023 08 25_Patent SEAL_ATO-Cu_FR_Final.pdf
Regulatory Filings Classification · 95% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIEE" (Press Release – Privileged Information) and is dated August 24, 2023. It announces a specific corporate event: the granting of a Chinese patent protecting the combined use of metal ions and arsenic salts for treating serious diseases. This type of announcement, which details a specific, material, non-financial corporate event (like IP protection or a clinical trial update) released via a press release, fits best under the general category for regulatory announcements that aren't standard financial reports (10-K, IR, ER, etc.). Since it is a specific, material announcement that doesn't fit the definitions for ER, IR, CAP, DIV, or DIRS, the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements. It is not an Earnings Release (ER) as it focuses on IP, not financial results. It is not an Interim Report (IR) or Annual Report (10-K). It is not a Call Transcript (CT). It is not a Report Publication Announcement (RPA) because it contains the substantive information itself, rather than just announcing that a report is available.
2023-08-24 French
BIOS_PR_2023-Aout_Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE" (Press Release – Regulated Information) and is dated 03/08/2023. The core content details an increase in the total number of voting rights and shares due to the conversion of convertible bonds, providing specific figures for capital, shares, and potential future shares. This type of mandatory disclosure regarding changes in the total number of shares and voting rights (the denominator for ownership calculations) is a specific regulatory filing related to capital structure changes and major shareholdings. While it touches upon capital changes (CAP) and major shareholding notifications (MRQ), the most precise fit for a mandatory disclosure announcing the current total share count and voting rights, often required under market regulations (like the Belgian law mentioned), is related to share capital changes or major ownership reporting. Since it explicitly details the 'Nombre total d'actions assorties de droits de vote' (Total number of shares with voting rights) and potential future shares from warrants/conversions, it strongly aligns with announcements concerning share capital structure changes or major shareholding thresholds. Given the options, 'Share Issue/Capital Change' (SHA) is the best fit as it directly reports the resulting share count after a capital event (conversion), or 'Major Shareholding Notification' (MRQ) as this data is crucial for that. However, the primary focus is the change in the total share count due to financing activities (convertible bond conversion). I will classify this as SHA (Share Issue/Capital Change) as the event causing the change is the conversion of debt into equity, which alters the capital structure, and the document provides the resulting share count.
2023-08-03 French
BIOS_PR_2023-August_Denominator_EN_Final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled "PRESS RELEASE – REGULATED INFORMATION" and its primary content details an "Information on the total number of voting rights and shares." It specifically mentions an increase due to the issuance of new shares following convertible bond conversion and cites compliance with Article 15 of the Belgian law regarding the publication of major shareholdings. This content directly relates to changes in the total number of shares and voting rights, which is a specific type of corporate action disclosure. This aligns best with the 'Share Issue/Capital Change' (SHA) category, as it reports the resulting change in the denominator (total shares/voting rights) following a capital event (conversion of debt to equity). It is not a general regulatory filing (RNS) because it is highly specific, nor is it a Director's Dealing (DIRS) or a Major Shareholding Notification (MRQ) which typically reports an individual's change in stake.
2023-08-03 English
BIOS_PR standstill_EN_2023 07 10_Final.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated July 10th, 2023, providing an update on negotiations with creditors and announcing plans for a future fundraising (private placement in Q3-4 2023). It discusses financial arrangements, debt renegotiation, and cash runway until October 2023. This content relates to the company's financial structure, capital needs, and ongoing financing activities, but it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a formal capital change announcement (CAP). Since it details the status of financial negotiations required for future fundraising, it best fits the 'Capital/Financing Update' category, which covers updates on fundraising and capital structure changes. It is not a formal report announcement (RPA) as it contains substantive updates, not just a notice of publication.
2023-07-10 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.